Literature DB >> 16897761

Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity.

Robert F Padera1, Julie Y Tse, Evangelia Bellas, Daniel S Kohane.   

Abstract

Conventional local anesthetics such as bupivacaine cause considerable myotoxicity and neurotoxicity, whereas tetrodotoxin (TTX) does not. Tetrodotoxin combined with bupivacaine or vasoconstrictors produces long-duration nerve blockade. To assess whether these prolonged blocks can be produced without increased myotoxicity, Sprague-Dawley rats were injected with bupivacaine, TTX, and both, or TTX plus epinephrine. Median durations of thermal nociceptive blockade were, respectively, 188, 401, 882, and 972 min. On dissection 4 days later, all tissues appeared macroscopically pristine. Muscle injury was at most mild to moderate in all animals, and the muscle injury scores for the combination formulations were not higher than for bupivacaine alone. Similarly, in differentiated cells from a myoblast cell line (C2C12), TTX caused either no or minimal worsening of cell viability from bupivacaine at 2 or 7 days. Epinephrine did not worsen TTX's relatively minimal cytotoxicity. Tetrodotoxin may thus be useful in producing prolonged nerve block with minimal myotoxicity and perhaps neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897761     DOI: 10.1002/mus.20618

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  28 in total

1.  A problem! Now a solution?

Authors:  Creig S Hoyt
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

2.  The Duration of Nerve Block from Local Anesthetic Formulations in Male and Female Rats.

Authors:  Kathleen Cullion; Laura C Petishnok; Tianjiao Ji; David Zurakowski; Daniel S Kohane
Journal:  Pharm Res       Date:  2019-11-08       Impact factor: 4.200

3.  Corneal Anesthesia With Site 1 Sodium Channel Blockers and Dexmedetomidine.

Authors:  James Brian McAlvin; Changyou Zhan; Jenny C Dohlman; Paraskevi E Kolovou; Borja Salvador-Culla; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

4.  Long-acting liposomal corneal anesthetics.

Authors:  Changyou Zhan; Claudia M Santamaria; Weiping Wang; J Brian McAlvin; Daniel S Kohane
Journal:  Biomaterials       Date:  2018-08-09       Impact factor: 12.479

5.  Toxicogenomic analysis of a sustained release local anesthetic delivery system.

Authors:  Iris Shichor; Noam Shomron; Michael W Lawlor; Seul A Bae; Janet Zoldan; Robert Langer; Daniel S Kohane
Journal:  Biomaterials       Date:  2012-02-16       Impact factor: 12.479

6.  Multivesicular liposomal bupivacaine at the sciatic nerve.

Authors:  J Brian McAlvin; Robert F Padera; Sahadev A Shankarappa; Gally Reznor; Albert H Kwon; Homer H Chiang; Jason Yang; Daniel S Kohane
Journal:  Biomaterials       Date:  2014-03-06       Impact factor: 12.479

7.  Transtympanic Delivery of Local Anesthetics for Pain in Acute Otitis Media.

Authors:  Rong Yang; Riitta Saarinen; Obiajulu S Okonkwo; Yi Hao; Manisha Mehta; Daniel S Kohane
Journal:  Mol Pharm       Date:  2019-03-06       Impact factor: 4.939

8.  Topical drug formulations for prolonged corneal anesthesia.

Authors:  Liqiang Wang; Sahadev A Shankarappa; Rong Tong; Joseph B Ciolino; Jonathan H Tsui; Homer H Chiang; Daniel S Kohane
Journal:  Cornea       Date:  2013-07       Impact factor: 2.651

9.  Prolonged nerve blockade delays the onset of neuropathic pain.

Authors:  Sahadev A Shankarappa; Jonathan H Tsui; Kristine N Kim; Gally Reznor; Jenny C Dohlman; Robert Langer; Daniel S Kohane
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

10.  Duration and local toxicity of sciatic nerve blockade with coinjected site 1 sodium-channel blockers and quaternary lidocaine derivatives.

Authors:  Sahadev A Shankarappa; Itay Sagie; Jonathan H Tsui; Homer H Chiang; Cristina Stefanescu; David Zurakowski; Daniel S Kohane
Journal:  Reg Anesth Pain Med       Date:  2012 Sep-Oct       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.